Clinical Trials · NCT01516255
Effect of Liraglutide on Heart Frequency in Healthy Volunteers
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 64
- Start date
- Jul 2006
- Locations
- 1 site, United States
- Primary endpoint
- Maximum time-matched mean difference between the baseline subtracted QTci intervals